Biotech Industry Gaining Popularity Among Venture Capital Asset Classes

Forbes - August 1, 2016 - "Biotech has been one of the hottest sectors in the venture capital asset class over the past new years. Strong IPO and M&A markets have put wind in the sails of the space since 2012, and robust investment activity has enabled a wave of well-funded biotechs to mature with a lower cost of capital than a decade ago.

Read full article here...